DYAI DYADIC INTERNATIONAL INC

Nasdaq dyadic.com


$ 1.12 $ -0.04 (-3.39 %)    

Friday, 24-Oct-2025 15:59:30 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 1.14
$ 1.19
$ 1.08 x 1
$ 1.49 x 250
$ 1.14 - $ 1.27
$ 0.71 - $ 2.20
127,653
na
41.25M
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-26-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-29-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-30-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-27-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-assumes-dyadic-international-at-buy-announces-price-target-of-3

HC Wainwright & Co. analyst Swayampakula Ramakanth assumes Dyadic International (NASDAQ:DYAI) with a Buy rating and anno...

 correction-dyadic-international-q2-eps-006-inline-sales-966630k-beat-600000k-estimate

Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. Thi...

 dyadic-international-prices--575m-public-offering-of-6052m-shares-of-common-stock-at-095share

Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on...

 dyadic-international-announces-proposed-public-offering-of-common-stock-no-size-or-amount-disclosed

Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on...

 dyadic-international-announces-coo-joe-hazelton-appointed-as-president-effective-immediately

Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth marketsLeadership team...

 dyadic-international-fy-2024-gaap-eps-020-beats-023-estimate-sales-350m-miss-430m-estimate

Dyadic International (NASDAQ:DYAI) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION